Diagnosis of Tuberculosis in Children and Adults
Clinical Infectious Disease 2017 |
PDF
(2.83 MB) |
01/2017 |
Treatment of Drug-Susceptible Tuberculosis
Clinical Infectious Disease 2016 |
PDF
(1MB) |
08/2016 |
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
MMWR 2013; 62 (No. 9) |
PDF
(411 KB) |
10/2013 |
Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013
MMWR 2013; 62 (No. 41) |
PDF
(275 KB) |
10/2013 |
| Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis |
PDF
(229 KB) |
6/2013 |
Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
MMWR 2011; 60:1650–1653 |
PDF
(1.1 MB) |
12/2011 |
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
MMWR 2010; 59 (RR-5); 1-25 |
PDF
(502 KB) |
6/2010 |
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
MMWR 2009; 58: 1-166 |
PDF
(2.2 MB) |
3/2009 |
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
MMWR 2009; 58: 1-198 |
PDF
(2.2 MB) |
3/2009 |
Plan to Combat Extensively Drug-Resistant Tuberculosis
MMWR 2009; 58 (RR-03) |
PDF
(752 KB) |
2/2009 |
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
MMWR 2009; 58 (01); 7-10 |
PDF
(1.2 MB) |
1/2009 |
| Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States |
|
11/2008 |
| Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis |
|
11/2008 |
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
MMWR 2006; 55 (No. RR–09, 1–44) |
PDF
(589 KB) |
7/2006 |
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005
MMWR 2005; 54 (No. RR-17) – Reprint
Note: The errata was removed. The corrections included in the errata have been incorporated into the reprinted guidelines.
|
PDF
(4.2 MB) |
12/2005 |
| Health Information for International Travel |
|
1/2005
–2006 |
Guidelines for Using the QuantiFERON–TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
MMWR 2005; 54 (No. RR–15, 1–37) |
PDF
(544 KB) |
12/2005 |
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
MMWR 2005; 54 (No. RR–15, 1–37) |
PDF
(544 KB) |
12/2005 |
Controlling Tuberculosis in the United States
Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
MMWR 2005; 54 (No. RR–12) |
PDF
(1.1 MB) |
11/2005 |
National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach
MMWR 2005; 54 (RR–6) |
PDF
(186 KB) |
4/2005 |
Errata: Treatment of Tuberculosis
MMWR 2005; 52 (RR–11) |
PDF
(499 KB) |
1/2005 |
New CDC Program for Rapid Genotyping of Mycobacterium tuberculosis Isolates
MMWR 2005; 54 (No. 02) |
PDF
(483 KB) |
1/2005 |
Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents
MMWR 2004; 53 (RR15) |
PDF
(1.9 MB) |
12/2004 |
Treating Opportunistic Infections Among HIV–Exposed and Infected Children
MMWR 2004; 53 (RR14) |
PDF
(742 KB) |
12/2004 |
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor – Alpha – California, 2002–2003
MMWR 2004; 53 (No. 30) |
PDF
(325 KB) |
8/2004 |
| Guide to the Application of Genotyping to Tuberculosis Prevention and Control |
PDF
(763 KB) |
6/2004 |
Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection
MMWR 2003; 52 (No. 31) |
PDF
(587 KB) |
8/2003 |
Treatment of Tuberculosis
MMWR 2003; 52 (No. RR–11)
|
PDF
(1.5 MB) |
6/2003 |
Guidelines for Environmental Infection Control in Health–Care Facilities
MMWR 2003; 52 (No. RR–10) |
PDF
(1.1 mB) |
6/2003 |
Timing of Tuberculosis Screening and Smallpox Vaccination – Recommendations for Using Smallpox Vaccine in a Pre–Event Vaccination Program
MMWR 2003; 52 (No. RR–7) |
PDF
(237 KB) |
4/2003 |
Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002
MMWR 2002; 51 (No. RR–8) |
PDF
(776 KB) |
6/2002 |
Progressing Toward Tuberculosis Elimination in Low–Incidence Areas of the United States
MMWR 2002; 51 (No. RR–5) |
PDF
(329 KB) |
5/2002 |
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)
MMWR 2002; 51 (No. RR–2). |
PDF
(6.3 MB) |
2/2002 |
Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report
MMWR 2001; 50 (No. RR–1) |
PDF
(550 KB) |
1/2001 |
Update: Nucleic Acid Amplification Tests for Tuberculosis
MMWR 2000; 49 (No. 26) |
PDF
(136 KB) |
7/2000 |
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
MMWR 2000; 49 (No. RR–6)
Updates |
PDF
(350 KB) |
6/2000 |
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR 2000; 49 (No. 9) |
PDF
(241 KB) |
3/2000 |
Diagnostic Standards and Classification of Tuberculosis in Adults and Children
Am J Respir Crit Care Med 2000; 161 |
PDF
(168 KB) |
2000 |
Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET)
MMWR 1999; 48 (No. RR–9) |
PDF
(211 KB) |
8/1999 |
Recommendations for Prevention and Control of Tuberculosis among Foreign–Born Persons
MMWR 1998; 47 (No. RR–16) |
PDF
(293 KB) |
9/1998 |
Development of new Vaccines for Tuberculosis
MMWR 1998; 47 (No. RR–13) |
PDF
(171 KB) |
8/1998 |
Nucleic Acid Amplification Tests for Tuberculosis.
MMWR 1996; 45 (No. 43) |
PDF
(303 KB) |
11/1996 |
Prevention and Control of Tuberculosis in Correctional Facilities (ACET)
MMWR 1996; 45 (No. RR–8) |
PDF
(313 KB) |
6/1996 |
The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP)
MMWR 1996; 45 (RR–4) |
PDF
(266 KB) |
4/1996 |
Essential Components of a Tuberculosis Prevention and Control Program (ACET)
MMWR 1995; 44 (No. RR–11) |
PDF
(358 KB) |
9/1995 |
Tuberculosis Control Laws – United States, 1993 (ACET)
MMWR 1993; 42 (No. RR–15) |
PDF
(253 KB) |
11/1993 |
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence
MMWR 1993; 42 (No. RR-4) |
PDF
(237 KB) |
04/1993 |
ShareCompartir
